Newsroom | 216131 results

SHANGHAI--(BUSINESS WIRE)--YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene-editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for YOLT-202, the company’s investigational in vivo base-editing therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). The FDA approval enables the initiation of an open-label, single-dose expansion Phase 2/3 clinical study...

NEW YORK--(BUSINESS WIRE)--Advanced eClinical Training (ACT) has expanded its nationwide clinical partner network to more than 1,000 healthcare sites....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 60,655 shares of its common stock to five newly hired employees, consisting of inducement stock options to purchase an aggregate of 24,506 shares of common stock and inducement restricted stock units, covering an aggregate of 36,149 shares of its common stock. The awards are subject to all terms and conditions and other provisio...

DANBURY, Conn.--(BUSINESS WIRE)--Fertility care that feels personal, empowering, and rooted in trust has arrived in Danbury. The Center for Advanced Reproductive Services (CARS), a nationally respected fertility center affiliated with the UConn School of Medicine, has opened its newest location at 73 Sand Pit Road—making exceptional fertility care more accessible to families in western Connecticut. At the heart of the new office is Dr. Maya Barsky (MD, MSCI), a board-certified reproductive endo...

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that on March 12, 2026 (Grant Date), the Compensation Committee of the Company’s Board of Directors granted an inducement award consisting of a non-qualified stock option to purchase 51,000 shares of Class A common st...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced that its Board of Directors has approved a new share repurchase program for the Company’s common stock, under which the Company may repurchase up to $10 million of outstanding shares of common stock. Pursuant to the authorization, repurchases may be made from time to time in the open market, including under Rule 10b5-1 plans, through...

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Conduent, a vendor for Priority Health, experienced a cybersecurity incident on January 13, 2025. Priority Health was informed on April 21, 2025. The delay in notification resulted primarily from the extensive and complex data sets that Conduent needed to analyze, followed by the validation and additional requirements necessary once the information was provided to Priority Health. The incident occurred in the systems of Conduent, a third-party vendor that p...

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (Nasdaq : HYFT), une société d'IA bio-native axée sur la découverte de produits biologiques et le développement de médicaments optimisé par l'IA, annonce aujourd'hui ses résultats financiers pour le troisième trimestre de l'exercice 2026, clos le 31 janvier 2026. MindWalk tiendra sa téléconférence sur les résultats du troisième trimestre de l'exercice 2026 aujourd'hui à 10h30, heure de l'Est. Le chiffre d'affaires du T3 s'établit à 4,2 mil...

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its fourth quarter and full year 2025 financial results and provide a business update on Thursday, March 26, 2026, at 4:30 p.m. ET, after market close. The company will issue a press release detailing its fourth quarter and full year financial results and business highlights o...